631 related articles for article (PubMed ID: 24833662)
21. Activation of V gamma 9V delta 2 T cells by NKG2D.
Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
[TBL] [Abstract][Full Text] [Related]
22. Clinical applications of gamma delta T cells with multivalent immunity.
Deniger DC; Moyes JS; Cooper LJ
Front Immunol; 2014; 5():636. PubMed ID: 25566249
[TBL] [Abstract][Full Text] [Related]
23. Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia.
Knight A; Piskacek M; Jurajda M; Prochazkova J; Racil Z; Zackova D; Mayer J
Cancer Immunol Immunother; 2023 May; 72(5):1209-1224. PubMed ID: 36376516
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 vaccination influences subtypes of γδ-T cells during pregnancy.
Wang L; Li J; Jiang S; Li Y; Guo R; Chen Y; Chen Y; Yu H; Qiao Q; Zhan M; Yin Z; Xiang Z; Xu C; Xu Y
Front Immunol; 2022; 13():900556. PubMed ID: 36311780
[TBL] [Abstract][Full Text] [Related]
25. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo.
Kabelitz D; Wesch D; Pitters E; Zöller M
J Immunol; 2004 Dec; 173(11):6767-76. PubMed ID: 15557170
[TBL] [Abstract][Full Text] [Related]
26. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
Front Immunol; 2019; 10():1997. PubMed ID: 31507601
[TBL] [Abstract][Full Text] [Related]
27. Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells.
Michishita Y; Hirokawa M; Guo YM; Abe Y; Liu J; Ubukawa K; Fujishima N; Fujishima M; Yoshioka T; Kameoka Y; Saito H; Tagawa H; Takahashi N; Sawada K
Int J Hematol; 2011 Sep; 94(3):230-240. PubMed ID: 21858446
[TBL] [Abstract][Full Text] [Related]
28. Suppressive activity of Vδ2
Schilbach K; Krickeberg N; Kaißer C; Mingram S; Kind J; Siegers GM; Hashimoto H
Cancer Immunol Immunother; 2020 Apr; 69(4):593-610. PubMed ID: 31982940
[TBL] [Abstract][Full Text] [Related]
29. Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.
Zhou J; Kang N; Cui L; Ba D; He W
Cell Mol Immunol; 2012 Jan; 9(1):34-44. PubMed ID: 21666706
[TBL] [Abstract][Full Text] [Related]
30. Distinct pattern of human Vdelta1 gammadelta T cells recognizing MICA.
Li J; Cui L; He W
Cell Mol Immunol; 2005 Aug; 2(4):253-8. PubMed ID: 16274622
[TBL] [Abstract][Full Text] [Related]
31. An innate-like Vδ1
Wu Y; Kyle-Cezar F; Woolf RT; Naceur-Lombardelli C; Owen J; Biswas D; Lorenc A; Vantourout P; Gazinska P; Grigoriadis A; Tutt A; Hayday A
Sci Transl Med; 2019 Oct; 11(513):. PubMed ID: 31597756
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.
Harly C; Peyrat MA; Netzer S; Déchanet-Merville J; Bonneville M; Scotet E
Blood; 2011 Mar; 117(10):2864-73. PubMed ID: 21233315
[TBL] [Abstract][Full Text] [Related]
33. Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.
Kato Y; Tanaka Y; Tanaka H; Yamashita S; Minato N
J Immunol; 2003 Apr; 170(7):3608-13. PubMed ID: 12646624
[TBL] [Abstract][Full Text] [Related]
34. Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human Spleen.
Wang C; Lai AY; Baiu DC; Smith KA; Odorico JS; Wilson K; Schreiber T; de Silva S; Gumperz JE
J Immunol; 2024 Jan; 212(2):284-294. PubMed ID: 37991420
[TBL] [Abstract][Full Text] [Related]
36. Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia.
Jin Z; Luo Q; Lu S; Wang X; He Z; Lai J; Chen S; Yang L; Wu X; Li Y
J Hematol Oncol; 2016 Nov; 9(1):126. PubMed ID: 27863523
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.
Alejenef A; Pachnio A; Halawi M; Christmas SE; Moss PA; Khan N
Clin Exp Immunol; 2014 Jun; 176(3):418-28. PubMed ID: 24547915
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic Changes of Peripheral γδ T Cell and Its Subsets in Patients With Coronary Artery Disease.
Li Y; Jiang S; Li J; Yin M; Yan F; Chen Y; Chen Y; Wu T; Cheng M; He Y; Liang H; Yu H; Qiao Q; Guo Z; Xu Y; Zhang Y; Xiang Z; Yin Z
Front Immunol; 2022; 13():900334. PubMed ID: 35874761
[TBL] [Abstract][Full Text] [Related]
39. [Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV/AIDS patients in vitro].
Chen WW; Wu XL; Nie WM; Xie YX; Wang L; Zhao M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):285-7. PubMed ID: 22394638
[TBL] [Abstract][Full Text] [Related]
40. Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2.
Marlin R; Pappalardo A; Kaminski H; Willcox CR; Pitard V; Netzer S; Khairallah C; Lomenech AM; Harly C; Bonneville M; Moreau JF; Scotet E; Willcox BE; Faustin B; Déchanet-Merville J
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3163-3168. PubMed ID: 28270598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]